{"id":39415,"date":"2021-06-03T15:19:23","date_gmt":"2021-06-03T05:19:23","guid":{"rendered":"https:\/\/hudson.org.au?post_type=hdsn_news_post&p=39415"},"modified":"2024-07-04T16:34:49","modified_gmt":"2024-07-04T06:34:49","slug":"state-of-the-art-genomic-sequencer-accelerates-inflammation-research","status":"publish","type":"hdsn_news_post","link":"https:\/\/hudson.org.au\/news\/state-of-the-art-genomic-sequencer-accelerates-inflammation-research\/","title":{"rendered":"State-of-the art genomic sequencer accelerates inflammation research"},"content":{"rendered":"\n

Hudson Institute of Medical Research is progressing its genomic and inflammation research thanks to the support of the Victorian Government and The Ian Potter Foundation, who assisted with the acquisition of an Illumina NextSeq2000, a new sequencing system that provides unprecedented genomic capacity to study inflammatory diseases and microbial diversity.<\/p>\n\n\n

\n
\"Dr
L\u2013R: Dr Sam Forster and Professor Elizabeth Hartland<\/em><\/figcaption><\/figure>\n<\/div>\n\n\n

The machine is only the third of its kind in Victoria, and the first in the Monash precinct. It will be located in the Gandel Genomics Centre at Hudson Institute, where it will be used by scientists to accelerate critical inflammation research by supporting both single-cell and complex tissue gene expression studies, whole-exome sequencing to identify genetic variants and microbiome<\/a> metagenomics in patients with chronic and debilitating inflammatory diseases<\/a>.<\/p>\n\n\n\n

Dr Sam Forster<\/a> leads the Microbiota and Systems Biology Laboratory<\/a> at Hudson Institute – his team is developing new treatments for inflammatory diseases, including inflammatory bowel disease (IBD)<\/a>, by targeting health-associated bacteria in the microbiome.<\/p>\n\n\n\n

\n

\u201cIn terms of capacity, the NextSeq2000 has supercharged our ability to understand how the microbiome can be used to prevent or treat inflammation. We can now measure a patient\u2019s inflammatory response with much higher precision, discover and sequence twice as many new bacterial species in the same amount of time as before, at about the third of the cost. It really does allow us to take the research to the next level,\u201d Dr Forster said.<\/p>\n<\/blockquote>\n\n\n\n

The Illumina NextSeq2000 was partially funded by the Victorian Government and The Ian Potter Foundation.<\/p>\n\n\n\n

Director and CEO Professor Elizabeth Hartland<\/a> said, \u201cThe Victorian Government\u2019s investment in the NextSeq2000 for Hudson Institute will allow us to accelerate our microbiome research so Victorian patients with inflammatory conditions, like IBD, can be helped sooner rather than later.<\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Hudson Institute of Medical Research is progressing its genomic and inflammation research with the acquisition of an Illumina NextSeq 2000, a new sequencing system that provides unprecedented genomic capacity to study inflammatory diseases and microbial diversity.…  Read more<\/a><\/p>\n","protected":false},"featured_media":39416,"menu_order":0,"template":"","issue":[],"tag":[124,98,125],"story-type":[122],"treatment-type":[123,95],"class_list":["post-39415","hdsn_news_post","type-hdsn_news_post","status-publish","has-post-thumbnail","hentry","tag-genomic-sequencing","tag-inflammation","tag-microbiome","story-type-institute","treatment-type-genomics","treatment-type-microbiome-medicine"],"acf":[],"yoast_head":"\nState-of-the art genomic sequencer accelerates inflammation research - Hudson Institute of Medical Research<\/title>\n<meta name=\"description\" content=\"The Illumina NextSeq2000, a new genomic sequencer will provide the genomic capacity to study inflammatory diseases and microbial diversity.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hudson.org.au\/news\/state-of-the-art-genomic-sequencer-accelerates-inflammation-research\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"State-of-the art genomic sequencer accelerates inflammation research\" \/>\n<meta property=\"og:description\" content=\"The Illumina NextSeq2000, a new genomic sequencer will provide the genomic capacity to study inflammatory diseases and microbial diversity.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/hudson.org.au\/news\/state-of-the-art-genomic-sequencer-accelerates-inflammation-research\/\" \/>\n<meta property=\"og:site_name\" content=\"Hudson Institute of Medical Research\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-04T06:34:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/hudson.org.au\/wp-content\/uploads\/2021\/08\/Sam-Forster-and-Liz-Hartland.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"400\" \/>\n\t<meta property=\"og:image:height\" content=\"393\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/hudson.org.au\\\/news\\\/state-of-the-art-genomic-sequencer-accelerates-inflammation-research\\\/\",\"url\":\"https:\\\/\\\/hudson.org.au\\\/news\\\/state-of-the-art-genomic-sequencer-accelerates-inflammation-research\\\/\",\"name\":\"State-of-the art genomic sequencer accelerates inflammation research - Hudson Institute of Medical Research\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hudson.org.au\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/hudson.org.au\\\/news\\\/state-of-the-art-genomic-sequencer-accelerates-inflammation-research\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/hudson.org.au\\\/news\\\/state-of-the-art-genomic-sequencer-accelerates-inflammation-research\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/hudson.org.au\\\/wp-content\\\/uploads\\\/2021\\\/08\\\/Sam-Forster-and-Liz-Hartland.jpeg\",\"datePublished\":\"2021-06-03T05:19:23+00:00\",\"dateModified\":\"2024-07-04T06:34:49+00:00\",\"description\":\"The Illumina NextSeq2000, a new genomic sequencer will provide the genomic capacity to study inflammatory diseases and microbial diversity.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/hudson.org.au\\\/news\\\/state-of-the-art-genomic-sequencer-accelerates-inflammation-research\\\/#breadcrumb\"},\"inLanguage\":\"en-AU\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/hudson.org.au\\\/news\\\/state-of-the-art-genomic-sequencer-accelerates-inflammation-research\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-AU\",\"@id\":\"https:\\\/\\\/hudson.org.au\\\/news\\\/state-of-the-art-genomic-sequencer-accelerates-inflammation-research\\\/#primaryimage\",\"url\":\"https:\\\/\\\/hudson.org.au\\\/wp-content\\\/uploads\\\/2021\\\/08\\\/Sam-Forster-and-Liz-Hartland.jpeg\",\"contentUrl\":\"https:\\\/\\\/hudson.org.au\\\/wp-content\\\/uploads\\\/2021\\\/08\\\/Sam-Forster-and-Liz-Hartland.jpeg\",\"width\":400,\"height\":393,\"caption\":\"Dr Sam Forster and Professor Elizabeth Hartland using Illumina NextSeq2000\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/hudson.org.au\\\/news\\\/state-of-the-art-genomic-sequencer-accelerates-inflammation-research\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/hudson.org.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/hudson.org.au\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"State-of-the art genomic sequencer accelerates inflammation research\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/hudson.org.au\\\/#website\",\"url\":\"https:\\\/\\\/hudson.org.au\\\/\",\"name\":\"Hudson Institute of Medical Research\",\"description\":\"Transforming lives through scientific discovery.\",\"publisher\":{\"@id\":\"https:\\\/\\\/hudson.org.au\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/hudson.org.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-AU\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/hudson.org.au\\\/#organization\",\"name\":\"Hudson Institute of Medical Research\",\"url\":\"https:\\\/\\\/hudson.org.au\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-AU\",\"@id\":\"https:\\\/\\\/hudson.org.au\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/hudson.org.au\\\/wp-content\\\/uploads\\\/2017\\\/05\\\/hudson-logo-1.jpg\",\"contentUrl\":\"https:\\\/\\\/hudson.org.au\\\/wp-content\\\/uploads\\\/2017\\\/05\\\/hudson-logo-1.jpg\",\"width\":1200,\"height\":316,\"caption\":\"Hudson Institute of Medical Research\"},\"image\":{\"@id\":\"https:\\\/\\\/hudson.org.au\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"State-of-the art genomic sequencer accelerates inflammation research - Hudson Institute of Medical Research","description":"The Illumina NextSeq2000, a new genomic sequencer will provide the genomic capacity to study inflammatory diseases and microbial diversity.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hudson.org.au\/news\/state-of-the-art-genomic-sequencer-accelerates-inflammation-research\/","og_locale":"en_US","og_type":"article","og_title":"State-of-the art genomic sequencer accelerates inflammation research","og_description":"The Illumina NextSeq2000, a new genomic sequencer will provide the genomic capacity to study inflammatory diseases and microbial diversity.","og_url":"https:\/\/hudson.org.au\/news\/state-of-the-art-genomic-sequencer-accelerates-inflammation-research\/","og_site_name":"Hudson Institute of Medical Research","article_modified_time":"2024-07-04T06:34:49+00:00","og_image":[{"width":400,"height":393,"url":"https:\/\/hudson.org.au\/wp-content\/uploads\/2021\/08\/Sam-Forster-and-Liz-Hartland.jpeg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/hudson.org.au\/news\/state-of-the-art-genomic-sequencer-accelerates-inflammation-research\/","url":"https:\/\/hudson.org.au\/news\/state-of-the-art-genomic-sequencer-accelerates-inflammation-research\/","name":"State-of-the art genomic sequencer accelerates inflammation research - Hudson Institute of Medical Research","isPartOf":{"@id":"https:\/\/hudson.org.au\/#website"},"primaryImageOfPage":{"@id":"https:\/\/hudson.org.au\/news\/state-of-the-art-genomic-sequencer-accelerates-inflammation-research\/#primaryimage"},"image":{"@id":"https:\/\/hudson.org.au\/news\/state-of-the-art-genomic-sequencer-accelerates-inflammation-research\/#primaryimage"},"thumbnailUrl":"https:\/\/hudson.org.au\/wp-content\/uploads\/2021\/08\/Sam-Forster-and-Liz-Hartland.jpeg","datePublished":"2021-06-03T05:19:23+00:00","dateModified":"2024-07-04T06:34:49+00:00","description":"The Illumina NextSeq2000, a new genomic sequencer will provide the genomic capacity to study inflammatory diseases and microbial diversity.","breadcrumb":{"@id":"https:\/\/hudson.org.au\/news\/state-of-the-art-genomic-sequencer-accelerates-inflammation-research\/#breadcrumb"},"inLanguage":"en-AU","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hudson.org.au\/news\/state-of-the-art-genomic-sequencer-accelerates-inflammation-research\/"]}]},{"@type":"ImageObject","inLanguage":"en-AU","@id":"https:\/\/hudson.org.au\/news\/state-of-the-art-genomic-sequencer-accelerates-inflammation-research\/#primaryimage","url":"https:\/\/hudson.org.au\/wp-content\/uploads\/2021\/08\/Sam-Forster-and-Liz-Hartland.jpeg","contentUrl":"https:\/\/hudson.org.au\/wp-content\/uploads\/2021\/08\/Sam-Forster-and-Liz-Hartland.jpeg","width":400,"height":393,"caption":"Dr Sam Forster and Professor Elizabeth Hartland using Illumina NextSeq2000"},{"@type":"BreadcrumbList","@id":"https:\/\/hudson.org.au\/news\/state-of-the-art-genomic-sequencer-accelerates-inflammation-research\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/hudson.org.au\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/hudson.org.au\/news\/"},{"@type":"ListItem","position":3,"name":"State-of-the art genomic sequencer accelerates inflammation research"}]},{"@type":"WebSite","@id":"https:\/\/hudson.org.au\/#website","url":"https:\/\/hudson.org.au\/","name":"Hudson Institute of Medical Research","description":"Transforming lives through scientific discovery.","publisher":{"@id":"https:\/\/hudson.org.au\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hudson.org.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-AU"},{"@type":"Organization","@id":"https:\/\/hudson.org.au\/#organization","name":"Hudson Institute of Medical Research","url":"https:\/\/hudson.org.au\/","logo":{"@type":"ImageObject","inLanguage":"en-AU","@id":"https:\/\/hudson.org.au\/#\/schema\/logo\/image\/","url":"https:\/\/hudson.org.au\/wp-content\/uploads\/2017\/05\/hudson-logo-1.jpg","contentUrl":"https:\/\/hudson.org.au\/wp-content\/uploads\/2017\/05\/hudson-logo-1.jpg","width":1200,"height":316,"caption":"Hudson Institute of Medical Research"},"image":{"@id":"https:\/\/hudson.org.au\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/hudson.org.au\/wp-json\/wp\/v2\/hdsn_news_post\/39415","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hudson.org.au\/wp-json\/wp\/v2\/hdsn_news_post"}],"about":[{"href":"https:\/\/hudson.org.au\/wp-json\/wp\/v2\/types\/hdsn_news_post"}],"version-history":[{"count":0,"href":"https:\/\/hudson.org.au\/wp-json\/wp\/v2\/hdsn_news_post\/39415\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hudson.org.au\/wp-json\/wp\/v2\/media\/39416"}],"wp:attachment":[{"href":"https:\/\/hudson.org.au\/wp-json\/wp\/v2\/media?parent=39415"}],"wp:term":[{"taxonomy":"issue","embeddable":true,"href":"https:\/\/hudson.org.au\/wp-json\/wp\/v2\/issue?post=39415"},{"taxonomy":"tag","embeddable":true,"href":"https:\/\/hudson.org.au\/wp-json\/wp\/v2\/tag?post=39415"},{"taxonomy":"story-type","embeddable":true,"href":"https:\/\/hudson.org.au\/wp-json\/wp\/v2\/story-type?post=39415"},{"taxonomy":"treatment-type","embeddable":true,"href":"https:\/\/hudson.org.au\/wp-json\/wp\/v2\/treatment-type?post=39415"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}